Skip to main content
# Title Research Member Research Year
41 Prognostic outcome of mesenchymal transition biomarkers in correlation with EGFR expression in epithelial ovarian carcinoma patients Israa Mostafa Kamal Mohammed 2022
42 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Dr. Dalia Osama Mohamed Ahmed 2022
43 Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2 Dr. Iman Hassan Ahmed Hamada 2022
44 Prognostic outcome of mesenchymal transition biomarkers in correlation with EGFR expression in epithelial ovarian carcinoma patients Prof. Eman Massad Zaki El-Hefny 2022
45 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
46 Association of follicular helper T and follicular regulatory T cells with severity and hyperglycemia in hospitalized COVID-19 patients Dr. Asmaa Mohamed Zahran Omar 2022
47 Genetic variation in FOXP3 and ROR‑γ genes in pediatric acute lymphocytic leukemia (ALL) patients: correlation with associated cytokines Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
48 Prognostic outcome of mesenchymal transition biomarkers in correlation with EGFR expression in epithelial ovarian carcinoma patients Dr. Marwa Tammam Ameen Hammam 2022
49 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Dr. Noha gaber sayed 2022
50 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Dr. Asmaa Mohamed Zahran Omar 2021